8-K: DHC Incurs $17.9M Incentive Fee, Receives $27.2M AlerisLife Dividend

Diversified Healthcare Trust announced a $17.9 million incentive management fee for 2025 and received a $27.2 million cash dividend from AlerisLife Inc., with more expected.

Summary

• Diversified Healthcare Trust (DHC) incurred a $17.9 million incentive management fee for the 2025 calendar year, which is payable in cash by January 30, 2026.
• The incentive management fee was calculated based on DHC's total shareholder return exceeding the total shareholder return of the MSCI U.S. REIT/Health Care REIT Index for the three-year measurement period ended December 31, 2025.
• DHC received a $27.2 million cash dividend from AlerisLife Inc. on January 9, 2026, in connection with AlerisLife's sale of all its assets and wind-down of its business.
• An additional cash dividend of approximately $3.0 million to $7.0 million is expected upon the completion of AlerisLife's business wind-down.

Sentiment

Score: 7

Explanation: The company's total shareholder return outperformed its benchmark, leading to an incentive fee, and it received a substantial cash dividend with more expected. These are positive indicators, though the fee represents an expense.

Positives

• Received a significant cash dividend of $27.2 million from AlerisLife Inc. on January 9, 2026.
• Expect to receive an additional cash dividend of approximately $3.0 million to $7.0 million from AlerisLife Inc. upon the completion of its business wind-down.
• The incurrence of the $17.9 million incentive management fee indicates that DHC's total shareholder return outperformed the MSCI U.S. REIT/Health Care REIT Index over the three-year measurement period ended December 31, 2025.

Negatives

• Incurred a $17.9 million incentive management fee for the 2025 calendar year, which is payable in cash by January 30, 2026.

Risks

• Future dividends from AlerisLife Inc. may not be received, or the amount or timing of any such dividends may change.
• Actual results may differ materially from forward-looking statements due to various factors.
• Other important factors that could cause actual results to differ materially are identified under the caption Risk Factors in the Annual Report on Form 10-K for the year ended December 31, 2024.

Future Outlook

DHC expects to receive an additional cash dividend of approximately $3.0 million to $7.0 million upon the completion of AlerisLife Inc.'s business wind-down. However, there is a warning that future dividends may not be received, or their amount and timing could change.

Management Comments

• Incurred an incentive management fee of $17.9 million for the 2025 calendar year under the Business Management Agreement.
• Received a cash dividend of $27.2 million from AlerisLife Inc. in connection with AlerisLife's sale of all its assets and wind-down of its business.
• Expect to receive an additional cash dividend of approximately $3.0 million to $7.0 million at the completion of the wind-down of AlerisLife's business.

Industry Context

The filing highlights DHC's performance relative to its peers in the healthcare REIT sector, as evidenced by the incentive fee calculation tied to the MSCI U.S. REIT/Health Care REIT Index. The receipt of dividends from AlerisLife Inc. reflects ongoing strategic adjustments and asset dispositions within the broader healthcare and senior living real estate industry, where companies may divest non-core assets or wind down operations to optimize portfolios or return capital to shareholders.

Comparison to Industry Standards

• The incentive management fee of $17.9 million was triggered because DHC's total shareholder return exceeded the total shareholder return of the MSCI U.S. REIT/Health Care REIT Index for the three-year measurement period ended December 31, 2025, indicating outperformance against a key industry benchmark for healthcare REITs.
• No specific comparable companies or projects are mentioned in the filing for direct comparison of the dividend received from AlerisLife Inc.

Related Party Transactions

• The $17.9 million incentive management fee is payable to The RMR Group LLC under the Business Management Agreement, which is a related party.

Stakeholder Impact

• Shareholders: Benefit from the company's outperformance against its benchmark (leading to the incentive fee) and the significant cash dividends received and expected from AlerisLife Inc. However, the incentive fee is an expense that reduces net income.
• The RMR Group LLC: Benefits from the $17.9 million incentive management fee.
• AlerisLife Inc. (former shareholders/creditors): The dividend distribution is part of its wind-down process.

Next Steps

• Payment of the $17.9 million incentive management fee by January 30, 2026.
• Recognition of the incentive management fee expense in financial statements for the year ended December 31, 2025.
• Completion of AlerisLife Inc.'s business wind-down, which is expected to result in an additional cash dividend.

Key Dates

Recommendation

While the outperformance against the benchmark and the significant dividend receipts are positive, the incentive fee represents a substantial expense. The future dividend from AlerisLife is an expectation with a cautionary note. The filing primarily reports past events and an expected future cash inflow, without providing broader operational or strategic updates that would warrant a strong buy or sell recommendation. It suggests a stable, but not necessarily rapidly accelerating, financial position based on these specific events.

Keywords

Diversified Healthcare Trust, DHC, REIT, healthcare, incentive fee, RMR Group, AlerisLife, dividend, asset sale, wind-down, financial results, 8-K, real estate